Form 8-K SURMODICS INC For: Apr 28
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
SurModics (SRDX) PT Raised to $68 at Needham & Company Following Earnings
April 28, 2021 3:59 PM EDTNeedham & Company analyst Mike Matson raised the price target on SurModics (NASDAQ: SRDX) to $68.00 (from $61.00) while maintaining a Buy rating.
The analyst commented, "SRDX F2Q21 revenue and EPS beat consensus. Revenue growth improved to 53.3% in F2Q21 from (1.4%) in... More
